Mid
P
PTCTAI Stock Diagnostic Report
Cantor Fitzgerald raises PTC Therapeutics stock price target on Sephience outlook
Cantor Fitzgerald has raised its price target for PTC Therapeutics based on the outlook for Sephience.
View Source Article ↗AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time